Picton Mahoney Asset Management Raises Stock Holdings in Azenta, Inc. (NASDAQ:AZTA)

Picton Mahoney Asset Management increased its position in Azenta, Inc. (NASDAQ:AZTA) by 305.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 706 shares of the company’s stock after acquiring an additional 532 shares during the period. Picton Mahoney Asset Management’s holdings in Azenta were worth $35,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. KBC Group NV raised its stake in Azenta by 48.5% in the 4th quarter. KBC Group NV now owns 2,137 shares of the company’s stock worth $107,000 after acquiring an additional 698 shares during the last quarter. Assenagon Asset Management S.A. purchased a new position in Azenta in the 4th quarter worth $200,000. Aigen Investment Management LP purchased a new position in Azenta in the 3rd quarter worth $214,000. Empowered Funds LLC purchased a new position in shares of Azenta during the 4th quarter valued at about $293,000. Finally, Stephens Inc. AR purchased a new position in shares of Azenta during the 4th quarter valued at about $313,000. Hedge funds and other institutional investors own 99.08% of the company’s stock.

Azenta Stock Up 0.7 %

NASDAQ:AZTA opened at $36.80 on Monday. Azenta, Inc. has a 52 week low of $35.90 and a 52 week high of $63.58. The stock has a market capitalization of $1.68 billion, a PE ratio of -12.35 and a beta of 1.52. The stock’s 50-day moving average price is $48.16 and its 200-day moving average price is $47.03.

Azenta (NASDAQ:AZTA) last posted its earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, beating analysts’ consensus estimates of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. Sell-side analysts expect that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. TD Cowen upgraded Azenta to a “hold” rating in a research note on Thursday, February 27th. Stephens reiterated an “overweight” rating and set a $60.00 price objective on shares of Azenta in a research note on Thursday, January 2nd. Needham & Company LLC lifted their price objective on Azenta from $55.00 to $59.00 and gave the company a “buy” rating in a research note on Thursday, February 6th. Finally, Evercore ISI lifted their price objective on Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a research note on Thursday, February 6th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, Azenta currently has an average rating of “Hold” and an average price target of $58.75.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.